Distinct sets of molecular characteristics define tumor-rejecting neoantigens
A. C. Adams, A. M. Macy, E. S. Borden, L. M. Herrmann, C. A. Brambley, T. Ma, X. Li, A. Hughes, D. J. Roe, A. R. Mangold, K. H. Buetow, M. A. Wilson, B. M. Baker, K. T. Hastings
The paper identifies molecular features of tumor-rejecting neoantigens in cSCC and shows how they differ from non-immunogenic neoantigens.
bioRxiv · Feb 13, 2024Immunology